Brian Culley, CEO, Lineage Cell Therapeutics talks about the risk we all face from developing age-related macular degeneration - both wet AMD and dry AMD. While there are treatments for wet AMD, currently there is no interventional approved treatment for dry AMD. Lineage is developing a ground-breaking treatment for dry AMD that includes injecting new retina cells into the back of the eye which then multiply and repair and even reverse the damage to the eye. @LineageCell #AMD #WetAMD #DryAMD #eyehealth #celltherapy LineageCell.com Download the transcript here.